Linustedastatum (Linustedastat, FOR-6219) is an orally active hydroxysteroid 17-beta dehydrogenase 1 (HSD17B1) inhibitor. Linustedastatum can be used for the study of endometriosis[1][2].
Molecular Weight:
453.52
Purity:
98.10
CAS Number:
[2254299-48-2]
Formula:
C26H29F2N3O2
Target:
17beta-HSD
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted